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The development of ethanol-induced liver injury including liver
cirrhosis and severe alcoholic steatohepatitis (ASH) is a complex
process involving various liver cell types and mainly factors
released under the control of the innate immune system. Chronic
ethanol consumption induces oxidative stress and production of
reactive oxygen species (ROS), cytokine release, mitochondrial
dysfunction, endoplasmic reticulum stress, and others. ROS initi-
ate lipid peroxidation that directly damages plasma and intracel-
lular membranes and leads to the production of reactive
aldehydes with potent pro-inﬂammatory and pro-ﬁbrotic proper-
ties. Oxidative stress and ROS are predominantly generated
through the induction of cytochrome P450-2E1 (CYP2E1). A key
role for this enzyme in ethanol-induced liver injury has been
demonstrated by its inhibition through chlormethiazole and by
the ﬁnding that CYP2E1 knock-out (KO) mice do not show evi-
dence of ethanol-induced liver disease [1]. Furthermore, trans-
genic overexpression of human CYP2E1 in a mouse model
results in more severe liver disease. Both the hydroxyethyl radi-
cal and acetaldehyde, the ﬁrst products of ethanol metabolism,
can bind glutathione (GSH), a tripeptide that acts as a direct free
radical scavenger. The transcription factor nuclear factor (ery-
throid-derived 2)-like 2 (Nrf2) protects cells against xenobiotic
and oxidative stress. Nrf2 KO mice exhibit a dramatically
increased mortality after ethanol feeding, highlighting the impor-
tant role of oxidative stress in ethanol-induced injury [1] (Fig. 1).Journal of Hepatology 20
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Kupffer cells are of particular importance in ethanol-induced
liver injury. Chronic ethanol exposure sensitizes Kupffer cells to
the activation by lipopolysaccharides (LPS) via toll-like receptor
4 (TLR4) [2]. This sensitization enhances the production of vari-
ous pro-inﬂammatory mediators, such as tumor necrosis factor-
a (TNFa) and ROS that contribute to hepatocyte dysfunction,
necrosis and apoptosis of hepatocytes, and the generation of
extracellular matrix proteins leading to ﬁbrosis/cirrhosis [3].
Apoptosis, a major form of cell death, has been observed in a
diverse spectrum of liver diseases. In experimental models and
isolated hepatocytes, alcohol has been shown to induce liver cell
apoptosis. Interestingly, the extent of apoptosis is correlated with
clinical disease activity. TNFa has emerged as a key factor in var-
ious aspects of liver diseases being able to mediate many clinical
aspects of severe ASH such as anorexia, fever, wasting, hypoalbu-
minemia, and neutrophilia. Some of the most deﬁnitive data
about the importance of TNFa in the pathogenesis of liver disease
have come from studies of alcoholic liver injury in animals
whereas clinical studies blocking this cytokine in human studies
of severe ASH have so far not proven successful. Plasma levels of
both TNF and soluble TNF receptors are correlated with endotox-
emia, impaired intestinal permeability, stage of liver disease, and
mortality. Alcohol-associated liver injury is inhibited when the
animals are treated with poorly absorbed oral antibiotics or lac-
tobacillus to decrease endotoxemia, supporting the hypothesis
that gut-derived bacterial products such as endotoxin might be
important in activation of Kupffer cells and/or other cell types
in the liver. This is in accordance with the recent observation that
chronic ethanol feeding causes more severe liver injury in wild-
type mice than in CD14 knock-outs [4]. These results further sup-
port the notion that gut-derived endotoxin acting via its cellular
receptor CD14 plays a major role in the development of early
alcohol-induced liver injury. Other pro-inﬂammatory cytokines,
however, might be of equal importance. Serum/plasma concen-
trations of IL-1, IL-6, and IL-8 have been shown to be increased
initially in hospitalized patients with alcoholic steatohepatitis
and to decline during recovery. Enhanced serum IL-1 activity
has been demonstrated in patients with severe ASH more than
20 years ago. Hepatic expression of IL-8, the critical chemokine
being responsible for neutrophil recruitment into the liver, corre-
lates with progression of patients with alcoholic hepatitis further
supporting the importance of cytokine circuits in those diseases
[5]. IL-17, another pro-inﬂammatory cytokine affecting neutro-
phil recruitment, is also highly activated in human alcoholic liver
disease and correlates with amount of liver inﬂammation [6]
(Fig. 1).11 vol. 55 j 1159–1161
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Fig. 1. Pathways of liver injury in alcoholic liver disease: central role of the innate immune system. After ingestion, ethanol is metabolized to acetaldyhyde by alcohol
dehydrogenases (ADH), by the microsomal ethanol oxidizing enzyme cytochrome P450-2E1 (CYP2E1), and by bacterial enzymes of the intestinal microbiota. Acetaldehyde
is then oxidized to acetate by aldehyde dehydrogenase (ALDH) and introduced into the citric acid (Krebs) cycle as acetyl-CoA. Chronic ethanol exposure increases the
production of reactive oxygen species (ROS). ROS are generated at different stages of ethanol metabolism and are highly toxic when surpassing the antioxidative capacity of
the hepatocyte. ROS activate redox-sensitive pro-inﬂammatory signaling pathways, they cause lipid peroxidation and lead to formation of protein and lipid adducts.
Oxidative stress is counterbalanced by induction of anti-oxidative transcription factors such as nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and/or hypoxia-inducible
factor 1 (Hif-1) that bind to antioxidant (ARE) and hypoxia response element (HRE) and induce the transcription of important detoxifying enzymes such as NADPH quinine
oxidoreductase-1 (NQO1), heme oxigenase-1 (HO-1), and glutathione S-transferase (GST). It has been suggested that pericentral hypoxia contributes to hepatic injury in
alcohol-induced liver injury. Chronic alcohol exposure increases the permeability of the gut mucosa resulting in translocation of bacterial products such as endotoxin into
the portal circulation. The gut-derived endotoxin activates its cellular receptors CD14 and Toll-like receptor 4 (TLR4), mainly on Kupffer cells but also on hepatocytes. CD14
KO mice are protected from the deleterious effects of chronic alcohol feeding. Activated liver cells then produce large amounts of pro-inﬂammatory cytokines such as TNF-
a, IL-1b, and IL-6. Other chemokines/cytokines such as IL-8 or IL-17 play a major role in neutrophilic inﬁltration of the liver. Adiponectin is a major anti-inﬂammatory
mediator that originates mainly from the adipose tissue. Adiponectin production is signiﬁcantly impaired in patients with chronic ethanol exposure. Interferon regulatory
factor 3 (IRF3)-mediated production of type I interferons by parenchymal cells has been demonstrated to suppress Kupffer cell activation via induction of the anti-
inﬂammatory cytokine IL-10 in ethanol-induced liver injury. Adiponectin is also a potent inducer of IL-10. Several other mechanisms have been demonstrated to be
involved in ethanol-induced liver injury such as the adenosine receptor type B or the endocannabinoid system. Adenine nucleotides (ADP and ATP) are released from
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Protective pathways impaired by chronic ethanol
administrationAnti-inﬂammatory protective strategies may be of critical
importance to protect the liver against ethanol toxicity.
Adiponectin, one of the most relevant anti-inﬂammatory adi-
pocytokines in humans, circulates at high concentrations in
healthy humans and chronic ethanol feeding decreases adipo-
nectin secretion by subcutaneous adipocytes. Adiponectin
improves both alcoholic and nonalcoholic fatty liver diseases
in mice [7]. Alcoholic fatty liver is associated with decreased
adiponectin levels, decreased expression of hepatic adiponec-
tin receptors, and impaired adiponectin liver signaling in ani-
mals. Decreased adiponectin availability may contribute not
only to hepatic steatosis but also to development of liver
inﬂammation. Kupffer cells from ethanol-fed rats are highly
sensitive to inhibition by adiponectin and this effect involves
an IL-10/Stat3/heme oxygenase-1 pathway. Importantly, via
such a mechanism, TLR4-dependent cytokine expression in
rat Kupffer cells and in mouse livers after chronic ethanol
exposure is suppressed. However, besides these pathways,
others may be of relevance such as adenosine. Blockade of
adenosine receptors type 2B decreases TNFa and IL-6 release
in sepsis models. Indeed, adenosine signaling via this receptor
contributes to ethanol-induced fatty liver in animals and tar-
geting this receptor may be effective in treatment of ethanol-
associated liver inﬂammation [8]. Evidence from rat studies
indicates that ethanol-induced gut leakiness/hyperpermeabil-
ity and endotoxemia precede liver inﬂammation suggesting
that, indeed, ethanol-induced gut damage comes ﬁrst [9]
(Fig. 1). Even though the described cytokine dysregulations
in fatty liver diseases may reﬂect a secondary phenomena,
blockade of these highly pro-inﬂammatory molecules remains
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